📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
47%
🔄 Reverse Split
65%
• 50-day avg $0.05 below $1 exchange minimum
• 9 months cash with weak price
📉 Score Deterioration
40%
• Score rose 17 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (9mo)
💹 Market Data
Market Cap$3.17M
Shares Outstanding101.29M
Float92.57M
Cash$172.5K
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest10.0K
Days to Cover1.0
% of Float0.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for AVCRF
📊 AVCRF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AVCRF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.